Protagonist Therapeutics, Inc. (PTGX)
105.98
+2.25
(+2.17%)
USD |
NASDAQ |
Apr 17, 16:00
106.05
+0.07
(+0.07%)
After-Hours: 20:00
Protagonist Therapeutics SG&A Expense (Quarterly) : 11.43M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Johnson & Johnson | 0.00 |
| AbbVie, Inc. | 3.895B |
| Insmed, Inc. | 212.48M |
| Madrigal Pharmaceuticals, Inc. | 239.98M |
| PTC Therapeutics, Inc. | 96.87M |